Add-on Acquisition • Life Science

The PharmEase Group Acquires Compound Preferred

On July 23, 2020, The PharmEase Group acquired life science company Compound Preferred

Acquisition Context
  • This is The PharmEase Group’s 1st transaction in the Life Science sector.
  • This is The PharmEase Group’s 1st transaction in the United States.
  • This is The PharmEase Group’s 1st transaction in Idaho.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date July 23, 2020
Target Compound Preferred
Sector Life Science
Buyer(s) The PharmEase Group
Deal Type Add-on Acquisition

Target Company

Compound Preferred

Idaho Falls, Idaho, United States
Compound Preferred is specialize in cGMP Compounding, Outsourcing Facility. Compound Preferred is based in Idaho Falls, Idaho.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

The PharmEase Group

Ammon, Idaho, United States

Category Company
Founded 2001
Sector Life Science
DESCRIPTION

The PharmEase Group is comprised of multiple companies including Heartland Long Term Care Pharmacy and Compound Preferred. The PharmEase Group was founded in 2001 and is based in Ammon, Idaho.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Add-on Acquisition 1 of 1
State: Idaho 1 of 1
Country: United States 1 of 1
Year: 2020 1 of 1